Challenges of Cost-Effectiveness Analyses of Novel Therapeutics for Inherited Retinal Diseases
Author:
Funder
National Institutes of Health
Publisher
Elsevier BV
Subject
Ophthalmology
Reference50 articles.
1. Cost-Effectiveness in Health and Medicine;Weinstein,1996
2. Estimating health-state utility for economic models in clinical studies: an ISPOR Good Research Practices Task Force Report;Wolowacz;Value Health,2016
3. First gene therapy in US is most expensive drug;Feuerstein;PharmacoEcon Outcomes News,2018
4. The cost-effectiveness of the Argus II retinal prosthesis in retinitis pigmentosa patients;Vaidya;BMC Ophthalmol,2014
5. Potential lifetime quality of life benefits of choroideremia gene therapy: projections from a clinically informed decision model;Halioua-Haubold;Eye (Lond),2019
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. EQ‐5D‐5L health utility scores in Australian adults with inherited retinal diseases: A cross‐sectional survey;Acta Ophthalmologica;2024-01-16
2. The economic burden of inherited retinal disease in Singapore: a prevalence-based cost-of-illness study;Eye;2023-06-10
3. A Review of Cost-Effectiveness Analyses for Open Angle Glaucoma Management;Journal of Glaucoma;2023-06-07
4. Dynamics of Covid-19 disease with its economic implications and optimal control: An exploitation of variational iteration method;Informatics in Medicine Unlocked;2023
5. Beyond the NEI-VFQ: Recent Experience in the Development and Utilization of Patient-Reported Outcomes for Inherited Retinal Diseases;Cold Spring Harbor Perspectives in Medicine;2022-10-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3